CollPlant Biotechnologies Ltd (OPHI) bonds

OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30

Share price

Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Debt

Borrowings on the balance sheet, Jun 30, 2026

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Individual notes, bonds and loans

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Parsed from the XBRL in CollPlant Biotechnologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 4, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OPHI.

Revenue growth360.4% · median -17.7%

Gross margin64.8% · median 24.3%

Operating margin-484.3% · median -946.7%

Net margin-484.6% · median -867.8%

Advertisement
300 × 250

See a number that looks wrong?